JAK-Inhibitor Review Delays Spur Talk Of US FDA Panel Meeting On Class Safety

 
• By Sue Sutter
Alarm clock
FDA reviews of new indications for JAK inhibitors are being slowed by safety concerns. • Source: Shutterstock

More from Product Reviews

More from Pink Sheet